Alvotech is trading at ISK 522.00, up +6.53%, after management reaffirmed 2026 revenue guidance: $650–700 million and adjusted EBITDA guidance: $180–220 million.

  • Production reportedly returned to planned levels near the end of Q2 after facility improvements constrained first-half output.
  • Prior results showed adjusted revenue falling to $211.9 million from $306.1 million, while adjusted EBITDA declined to $46.9 million from $53.7 million.
  • The move appears focused on forward guidance and operational recovery, rather than stronger first-half results.